Johnson & Johnson leads the orthopedic device market with a quarter of the market share; however it's expected to drop around 3 percent over the next five years. Stryker, NuVasive and Globus Medical are expected to have slight gains over that time period while others leaders are also expected to drop.
Here is the breakdown for 2016 market share and predictions for 2022, according to Statista.
1. Johnson & Johnson had 25.1 percent market share in 2016 and is expected to have 22.8 percent in 2022.
2. Zimmer Biomet had 20.7 percent market share in 2016 and is expected to have 19.8 percent in 2022.
3. Stryker had 16.1 percent market share in 2016 and is expected to have 17.1 percent in 2022.
4. Medtronic had 7.9 percent market share in 2016 and is expected to have 8.4 percent in 2022.
5. Smith & Nephew had 5.7 percent market share in 2016 and is expected to have 5.5 percent in 2022.
6. Arthrex had 4.9 percent market share in 2016 and is expected to have the same, 4.9 percent, in 2022.
7. NuVasive had 2.5 percent market share in 2016 and is expected to have 2.9 percent in 2022.
8. Wright Medical Group had 2 percent market share in 2016 and is expected to have 2.9 percent in 2022.
9. Globus Medical had 1.6 percent market share in 2016 and is expected to have 2 percent in 2022.
10. Orthofix had 1.2 percent market share in 2016 and is expected to have 1.1 percent in 2022.